marketcaparena
Search

    ORGO

    Organogenesis Holdings Inc.

    Company overview

    Market capitalization
    $177.57M
    Employees
    854
    Latest publication
    2026-09-29
    About Organogenesis Holdings Inc.

    Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barrier to provide a protective barrier and ECM scaffold to support native healing; PuraPly Antimicrobial (AM) and PuraPly SX, which are antimicrobial barriers for the management of open wounds in surgical settings; and CYGNUS Dual, VIA Matrix, and SimpliMax are placental tissue grafts used to treat chronic and acute wounds that can be stored at room temperature. The company also provides PuraPly MZ, a micronized version of PuraPly for the management of open wounds in surgical settings; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; and TransCyte, a bioengineered tissue scaffold that promotes burn healing. In addition, it develops ReNu, a cryopreserved suspension, which is in Phase 3 trial, for the management of symptoms associated with knee osteoarthritis; and placental products. The company serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices through direct sales representatives and independent agencies. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USDQ4 20222022-12-31 · USD
    Total Revenue43,755,000USD225,071,000USD150,487,000USD126,656,000USD115,177,000USD108,531,000USD117,316,000USD115,516,000USD
    Research Development18,297,000USD10,286,000USD13,221,000USD11,530,000USD10,344,000USD10,470,000USD10,938,000USD11,395,000USD
    Selling General Administrative53,965,000USD100,174,000USD79,743,000USD70,031,000USD71,795,000USD64,222,000USD70,317,000USD63,481,000USD
    Total Operating Expenses94,747,000USD109,924,000USD92,587,000USD85,386,000USD82,139,000USD74,692,000USD81,255,000USD79,688,000USD
    Operating Income-50,992,000USD65,229,000USD21,649,000USD10,219,000USD6,242,000USD8,050,000USD9,745,000USD8,718,000USD
    Total Other Income Expense Net112,000USD-1,802,000USD-489,000USD34,000USD-419,000USD-413,000USD-566,000USD36,000USD
    Interest Expense-138,000USD236,000USD415,000USD61,000USD471,000USD444,000USD594,000USD30,000USD
    Income Before Tax-50,880,000USD63,427,000USD21,160,000USD10,253,000USD5,823,000USD7,637,000USD9,179,000USD8,754,000USD
    Income Tax Expense45,387,000USD19,727,000USD-407,000USD2,580,000USD-6,508,000USD4,470,000USD3,863,000USD1,268,000USD
    Net Income-96,267,000USD43,700,000USD21,567,000USD7,673,000USD12,331,000USD3,167,000USD5,316,000USD7,486,000USD
    Net Income Applicable To Common Shares-99,339,000USD—————5,316,000USD6,486,000USD
    Cost Of Revenue—49,918,000USD36,251,000USD31,051,000USD26,796,000USD25,789,000USD26,316,000USD27,110,000USD
    Gross Profit—175,153,000USD114,236,000USD95,605,000USD88,381,000USD82,742,000USD91,000,000USD88,406,000USD
    Net Interest Income—236,000USD415,000USD61,000USD-471,000USD-444,000USD-594,000USD30,000USD
    Tax Provision—19,727,000USD-407,000USD2,580,000USD-6,508,000USD4,470,000USD3,863,000USD1,268,000USD
    Net Income From Continuing Ops—43,700,000USD21,567,000USD7,673,000USD12,331,000USD3,167,000USD5,316,000USD6,486,000USD
    Ebit—63,427,000USD21,160,000USD10,192,000USD6,294,000USD8,081,000USD9,773,000USD8,724,000USD
    Ebitda—70,440,000USD28,147,000USD14,641,000USD10,698,000USD13,926,000USD13,230,000USD13,279,000USD
    Depreciation And Amortization—7,013,000USD6,987,000USD4,449,000USD4,404,000USD5,845,000USD3,457,000USD4,555,000USD
    Reconciled Depreciation—7,013,000USD4,871,000USD4,449,000USD4,404,000USD3,774,000USD3,457,000USD4,555,000USD
    Interest Income——415,000USD————30,000USD
    Selling And Marketing Expenses———3,825,000USD———4,812,000USD
    Non Operating Income Net Other———————6,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue563,030,000USD482,043,000USD433,140,000USD450,893,000USD467,359,000USD338,298,000USD0USD98,975,000USD
    Cost Of Revenue137,522,000USD115,741,000USD106,481,000USD105,019,000USD114,199,000USD87,319,000USD208,698USD46,450,000USD
    Gross Profit425,508,000USD366,302,000USD326,659,000USD345,874,000USD353,160,000USD250,979,000USD-208,698USD52,525,000USD
    Research Development44,542,000USD50,271,000USD44,380,000USD39,762,000USD30,742,000USD20,086,000USD6,277,000USD3,882,000USD
    Selling General Administrative326,236,000USD290,688,000USD264,529,000USD278,996,000USD244,678,000USD200,756,000USD208,700USD25,160USD
    Total Operating Expenses369,639,000USD367,585,000USD314,134,000USD323,570,000USD280,942,000USD224,279,000USD208,698USD124,554,000USD
    Operating Income55,869,000USD-1,283,000USD12,525,000USD22,304,000USD72,218,000USD26,700,000USD208,698USD-25,160USD
    Interest Income2,281,000USD———————
    Interest Expense2,281,000USD1,544,000USD2,190,000USD2,009,000USD7,236,000USD11,279,000USD5,627,000USD0USD
    Net Interest Income2,281,000USD-1,544,000USD-1,658,000USD-2,009,000USD-7,236,000USD-11,279,000USD——
    Income Before Tax46,970,000USD-2,807,000USD10,392,000USD20,282,000USD63,086,000USD17,764,000USD-208,698USD-25,160USD
    Income Tax Expense9,938,000USD-3,668,000USD5,447,000USD4,750,000USD-31,116,000USD530,000USD-440,212USD-177,000USD
    Tax Provision9,938,000USD-3,668,000USD7,943,000USD4,750,000USD-31,116,000USD530,000USD——
    Net Income37,032,000USD861,000USD4,945,000USD15,532,000USD94,202,000USD17,234,000USD-208,698USD-25,160USD
    Net Income From Continuing Ops37,032,000USD861,000USD12,999,000USD15,532,000USD94,902,000USD17,949,000USD-208,698USD-22,425,000USD
    Ebit46,970,000USD-1,263,000USD12,582,000USD22,291,000USD70,322,000USD29,043,000USD-208,698USD-25,579,000USD
    Ebitda73,908,000USD15,763,000USD36,031,000USD40,322,000USD86,998,000USD37,226,000USD7,110,302USD—
    Depreciation And Amortization26,938,000USD17,026,000USD23,449,000USD18,031,000USD16,676,000USD8,183,000USD7,319,000USD—
    Reconciled Depreciation26,938,000USD17,026,000USD21,193,000USD18,031,000USD16,676,000USD7,468,000USD——
    Total Other Income Expense Net-8,899,000USD-1,524,000USD-2,133,000USD-2,022,000USD-9,132,000USD-8,936,000USD8,566,302USD2,977,000USD
    Selling And Marketing Expenses—3,825,000USD5,225,000USD4,812,000USD5,522,000USD2,722,000USD——
    Unclassified Operating Expenses—22,801,000USD————-6,277,002USD120,646,840USD
    Non Operating Income Net Other———-13,000USD-1,896,000USD2,343,000USD——
    Net Income Applicable To Common Shares———15,532,000USD94,902,000USD17,949,000USD-16,987,000USD-25,160USD
    Minority Interest——————6,099,000USD6,099,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets406,446,000USD519,991,999USD598,730,000USD509,827,000USD461,128,000USD467,394,000USD497,886,000USD446,296,000USD
    Cash And Equivalents46,097,000USD———————
    Total Current Assets200,302,000USD268,501,000USD362,188,000USD299,749,000USD260,223,000USD268,160,000USD285,941,000USD238,509,000USD
    Other Current Assets19,628,000USD31,069,000USD21,431,000USD27,011,000USD33,723,000USD25,537,000USD14,290,000USD15,861,000USD
    Other Non Current Assets22,925,000USD———————
    Total Liabilities118,314,000USD———————
    Total Current Liabilities56,963,000USD76,021,000USD100,124,000USD90,319,000USD65,839,000USD65,053,000USD77,477,000USD77,281,000USD
    Other Non Current Liabilities3,714,000USD———————
    Total Stockholder Equity148,268,000USD381,347,000USD433,918,000USD385,979,000USD361,219,000USD368,069,000USD385,316,000USD278,547,000USD
    Total Equity Including Noncontrolling Interest288,132,000USD———————
    Net Receivables100,937,000USD116,908,000USD217,451,000USD168,783,000USD120,382,000USD103,320,000USD109,861,000USD101,272,000USD
    Inventory29,280,000USD28,425,000USD29,627,000USD39,583,000USD33,042,000USD29,338,000USD26,219,000USD27,036,000USD
    Property Plant Equipment Net151,443,000USD157,820,000USD159,460,000USD111,362,000USD110,864,000USD112,274,000USD126,238,000USD124,811,000USD
    Goodwill28,772,000USD———————
    Intangible Assets3,004,000USD3,437,000USD9,145,000USD9,943,000USD10,785,000USD11,626,000USD12,468,000USD13,302,000USD
    Accounts Payable29,291,000USD28,615,000USD31,949,000USD40,219,000USD29,723,000USD24,660,000USD28,911,000USD23,971,000USD
    Short Term Debt3,807,000USD9,723,000USD18,642,000USD9,790,000USD9,768,000USD9,258,000USD9,113,000USD18,494,000USD
    Common Stock13,000USD13,000USD13,000USD13,000USD13,000USD13,000USD13,000USD13,000USD
    Retained Earnings-152,501,000USD-56,234,000USD-3,078,000USD-46,778,000USD-68,345,000USD-58,953,000USD-40,110,000USD-47,783,000USD
    Total Liab—138,645,000USD164,812,000USD123,848,000USD99,909,000USD99,325,000USD112,570,000USD167,749,000USD
    Other Current Liab—37,683,000USD49,533,000USD40,310,000USD23,493,000USD30,960,000USD35,167,000USD34,650,000USD
    Capital Stock—136,805,000USD133,802,000USD130,864,000USD127,990,000USD125,180,000USD122,432,000USD13,000USD
    Good Will—28,772,000USD28,772,000USD28,772,000USD28,772,000USD28,772,000USD28,772,000USD28,772,000USD
    Cash—92,099,000USD93,679,000USD64,372,000USD73,076,000USD109,965,000USD135,571,000USD94,340,000USD
    Cash And Short Term Investments—92,099,000USD93,679,000USD64,372,000USD73,076,000USD109,965,000USD135,571,000USD94,340,000USD
    Net Debt—-21,238,000USD39,165,000USD-23,562,000USD-32,260,000USD-67,332,000USD-92,259,000USD13,328,000USD
    Short Long Term Debt Total—70,861,000USD132,844,000USD40,810,000USD40,816,000USD42,633,000USD43,312,000USD107,668,000USD
    Property Plant Equipment Gross—157,820,000USD247,567,000USD195,465,000USD190,965,000USD188,643,000USD199,187,000USD199,977,000USD
    Common Stock Shares Outstanding—127,797,013shares132,206,983shares130,848,995shares126,853,536shares126,295,642shares132,162,370shares133,926,755shares
    Non Current Assets Total—251,491,000USD236,542,000USD210,077,999USD200,905,000USD199,234,000USD211,945,000USD207,787,000USD
    Non Current Liabilities Total—62,624,000USD64,688,000USD33,528,999USD34,070,000USD34,272,000USD35,093,000USD90,468,000USD
    Non Current Liabilities Other—1,486,000USD1,193,000USD2,509,000USD3,022,000USD897,000USD894,000USD1,294,000USD
    Non Currrent Assets Other—16,129,000USD9,203,000USD14,409,999USD8,730,000USD5,834,000USD5,005,000USD5,013,000USD
    Net Working Capital—192,480,000USD262,064,000USD209,430,000USD194,384,000USD203,107,000USD208,464,000USD161,228,000USD
    Unclassified Non Current Assets—45,333,000USD29,962,000USD45,591,000USD41,754,000USD40,728,000USD39,462,000USD35,889,000USD
    Unclassified Non Current Liabilities—61,138,000USD63,495,000USD31,019,999USD31,048,000USD33,375,000USD34,199,000USD33,021,000USD
    Unclassified Equity—300,763,000USD303,181,000USD301,880,000USD301,561,000USD301,829,000USD302,981,000USD326,304,000USD
    Current Deferred Revenue————2,680,000USD——12,450,000USD
    Unclassified Current Liabilities——————4,286,000USD-18,248,000USD
    Short Long Term Debt———————5,964,000USD
    Long Term Debt———————56,153,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets598,730,000USD497,886,000USD460,025,000USD449,359,000USD443,259,000USD290,218,000USD220,687,000USD163,678,000USD
    Intangible Assets9,145,000USD12,468,000USD15,871,000USD20,789,000USD25,673,000USD30,622,000USD20,797,000USD26,091,000USD
    Other Current Assets21,431,000USD14,290,000USD10,454,000USD5,898,000USD5,568,000USD5,347,000USD3,149,000USD2,442,000USD
    Total Liab164,812,000USD112,570,000USD181,362,000USD183,690,000USD201,924,000USD148,410,000USD165,104,000USD116,637,000USD
    Total Stockholder Equity433,918,000USD385,316,000USD278,663,000USD265,669,000USD241,335,000USD141,808,000USD55,583,000USD47,041,000USD
    Other Current Liab49,533,000USD35,167,000USD27,275,000USD23,822,000USD37,565,000USD24,551,000USD28,450,000USD37,442,000USD
    Common Stock13,000USD13,000USD13,000USD13,000USD13,000USD13,000USD10,000USD9,000USD
    Capital Stock133,802,000USD122,432,000USD13,000USD13,000USD13,000USD13,000USD10,000USD9,000USD
    Retained Earnings-3,078,000USD-40,110,000USD-40,971,000USD-45,301,000USD-60,833,000USD-155,035,000USD-171,007,000USD-130,240,000USD
    Good Will28,772,000USD28,772,000USD28,772,000USD28,772,000USD28,772,000USD28,772,000USD25,539,000USD25,539,000USD
    Cash93,679,000USD135,571,000USD104,338,000USD102,478,000USD113,929,000USD84,394,000USD60,174,000USD21,291,000USD
    Cash And Short Term Investments93,679,000USD135,571,000USD104,338,000USD102,478,000USD113,929,000USD84,394,000USD60,174,000USD21,291,000USD
    Total Current Assets362,188,000USD285,941,000USD225,044,000USD222,609,000USD226,979,000USD174,344,000USD125,600,000USD71,131,000USD
    Total Current Liabilities100,124,000USD77,477,000USD80,509,000USD75,023,000USD82,705,000USD68,217,000USD59,894,000USD66,388,000USD
    Net Debt39,165,000USD-92,259,000USD15,013,000USD21,313,000USD18,374,000USD377,000USD40,432,000USD37,971,000USD
    Short Term Debt18,642,000USD9,113,000USD19,711,000USD16,246,000USD14,641,000USD20,285,000USD3,057,000USD4,781,000USD
    Short Long Term Debt Total132,844,000USD43,312,000USD119,351,000USD123,791,000USD132,303,000USD84,771,000USD100,606,000USD59,262,000USD
    Net Receivables217,451,000USD109,861,000USD81,999,000USD89,450,000USD82,460,000USD56,804,000USD39,359,000USD34,077,000USD
    Inventory29,627,000USD26,219,000USD28,253,000USD24,783,000USD25,022,000USD27,799,000USD22,918,000USD13,321,000USD
    Accounts Payable31,949,000USD28,911,000USD30,724,000USD32,330,000USD29,339,000USD23,381,000USD28,387,000USD19,165,000USD
    Property Plant Equipment Net159,460,000USD126,238,000USD156,346,000USD145,655,000USD128,304,000USD55,792,000USD47,184,000USD39,623,000USD
    Property Plant Equipment Gross247,567,000USD199,187,000USD229,532,000USD145,655,000USD128,304,000USD60,068,000USD47,184,000USD39,623,000USD
    Common Stock Shares Outstanding130,248,412shares131,673,278shares132,746,727shares132,383,152shares133,662,658shares111,360,831shares92,840,401shares69,318,456shares
    Non Current Assets Total236,542,000USD211,945,000USD234,981,000USD226,750,000USD216,280,000USD115,874,000USD95,087,000USD92,547,000USD
    Non Current Liabilities Total64,688,000USD35,093,000USD100,853,000USD108,667,000USD119,219,000USD80,193,000USD105,210,000USD50,249,000USD
    Non Current Liabilities Other1,193,000USD894,000USD1,213,000USD42,436,000USD48,450,000USD11,956,000USD6,649,000USD903,000USD
    Non Currrent Assets Other9,203,000USD5,005,000USD-9,881,000USD1,520,000USD1,537,000USD670,000USD1,440,000USD579,000USD
    Net Working Capital262,064,000USD208,464,000USD144,535,000USD147,586,000USD144,974,000USD106,127,000USD65,706,000USD4,743,000USD
    Unclassified Non Current Assets29,962,000USD39,462,000USD33,991,999USD———-1,440,000USD—
    Unclassified Non Current Liabilities63,495,000USD34,199,000USD38,895,000USD-1,122,000USD-2,780,000USD—7,690,000USD3,905,000USD
    Unclassified Equity303,181,000USD302,981,000USD319,608,000USD310,944,000USD302,142,000USD296,817,000USD292,382,000USD239,698,000USD
    Unclassified Current Liabilities—4,286,000USD-2,687,000USD-1,913,000USD-37,218,000USD-39,158,000USD-22,640,000USD-27,960,000USD
    Other Assets——1USD31,534,000USD33,531,000USD688,000USD1,567,000USD1,294,000USD
    Short Long Term Debt——5,486,000USD4,538,000USD2,656,000USD16,666,000USD—2,545,000USD
    Long Term Debt——60,745,000USD66,231,000USD70,769,000USD53,044,000USD83,118,000USD39,062,000USD
    Accumulated Other Comprehensive Income——0USD0USD0USD—-65,812,000USD-62,435,000USD
    Other Liab———1,122,000USD1,557,000USD15,707,000USD7,661,000USD6,061,000USD
    Net Tangible Assets———216,108,000USD187,590,000USD86,690,000USD9,247,000USD-4,589,000USD
    Deferred Long Term Liab————1,223,000USD370,000USD92,000USD318,000USD
    Current Deferred Revenue————35,722,000USD22,492,000USD22,640,000USD30,415,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-53,156,000USD43,700,000USD21,567,000USD-9,392,000USD-18,843,000USD7,673,000USD12,331,000USD-17,043,000USD
    Depreciation12,370,000USD7,013,000USD6,987,000USD4,575,000USD6,283,000USD6,420,000USD4,404,000USD4,200,000USD
    Stock Based Compensation3,636,000USD4,324,000USD3,065,000USD2,542,000USD3,367,000USD2,891,000USD2,712,000USD2,568,000USD
    Other Non Cash Items3,122,000USD12,422,000USD5,177,000USD8,548,000USD11,237,000USD6,455,000USD5,294,000USD22,573,000USD
    Change To Account Receivables104,502,000USD-51,478,000USD-50,688,000USD-19,305,000USD5,668,000USD-8,804,000USD2,982,000USD-10,861,000USD
    Change To Inventory-8,730,000USD-2,961,000USD938,000USD-7,160,000USD-8,732,000USD-455,000USD7,893,000USD2,661,000USD
    Change In Working Capital70,526,000USD-43,668,000USD-29,880,000USD-38,120,000USD-20,713,000USD-6,779,000USD-13,848,000USD-7,560,000USD
    Total Cash From Operating Activities21,127,000USD39,420,000USD3,079,000USD-32,873,000USD-19,935,000USD10,937,000USD8,695,000USD4,738,000USD
    Capital Expenditures-3,146,000USD-4,652,000USD-2,235,000USD-3,638,000USD-3,626,000USD-3,361,000USD-2,569,000USD-1,880,000USD
    Free Cash Flow17,981,000USD34,768,000USD844,000USD-36,511,000USD-23,561,000USD7,576,000USD6,126,000USD2,858,000USD
    Total Cashflows From Investing Activities-3,146,000USD-4,652,000USD-2,235,000USD-3,638,000USD-3,626,000USD-3,361,000USD-2,569,000USD-1,880,000USD
    Net Borrowings-9,840,000USD-302,000USD-296,000USD-288,000USD-285,000USD-62,621,000USD-1,682,000USD—
    Total Cash From Financing Activities-20,213,000USD-4,809,000USD-10,207,000USD-288,000USD-2,056,000USD33,649,000USD-1,677,000USD-1,727,000USD
    Dividends Paid-3,003,000USD-190,000USD-5,622,000USD-2,810,000USD-1,798,000USD-1,798,000USD——
    Change In Cash-2,232,000USD29,959,000USD-9,363,000USD-36,799,000USD-25,617,000USD41,225,000USD4,449,000USD1,131,000USD
    Begin Period Cash Flow94,331,000USD64,372,000USD73,735,000USD110,534,000USD136,151,000USD94,926,000USD90,477,000USD89,346,000USD
    End Period Cash Flow92,099,000USD94,331,000USD64,372,000USD73,735,000USD110,534,000USD136,151,000USD94,926,000USD90,477,000USD
    Other Cashflows From Financing Activities-10,373,000USD-4,509,000USD-10,041,000USD2,810,000USD-1,796,000USD-2,000USD1,000USD-54,000USD
    Unclassified Operating Cash Flow-15,371,000USD15,629,000USD-3,837,000USD-1,026,000USD-1,266,000USD-5,723,000USD-2,198,000USD—
    Unclassified Financing Cash Flow3,003,000USD—5,752,000USD—1,823,000USD123,549,000USD—-1,673,000USD
    Investments——-2,235,000USD-3,638,000USD-3,626,000USD-3,361,000USD-2,569,000USD-1,880,000USD
    Unclassified Investing Cash Flow——2,235,000USD3,638,000USD3,626,000USD3,361,000USD2,569,000USD1,880,000USD
    Sale Purchase Of Stock—————-25,479,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income37,032,000USD861,000USD4,945,000USD15,532,000USD94,902,000USD17,234,000USD-40,454,000USD-64,831,000USD
    Depreciation26,938,000USD17,026,000USD23,449,000USD10,728,000USD16,676,000USD8,183,000USD9,431,000USD6,978,000USD
    Stock Based Compensation13,298,000USD10,578,000USD8,996,000USD6,552,000USD3,864,000USD1,661,000USD936,000USD1,075,000USD
    Other Non Cash Items35,304,000USD45,351,000USD9,588,000USD24,149,000USD17,800,000USD6,033,000USD6,115,000USD18,254,000USD
    Change To Account Receivables-115,803,000USD-31,800,000USD5,539,000USD-8,770,000USD-30,232,000USD-17,567,000USD-4,691,000USD-7,110,000USD
    Change To Inventory-17,915,000USD-6,204,000USD6,580,000USD-9,410,000USD-9,302,000USD-6,700,000USD-11,063,000USD-5,000,000USD
    Change In Working Capital-132,381,000USD-48,889,000USD-18,073,000USD-34,082,000USD-39,288,000USD-27,757,000USD-9,667,000USD-22,401,000USD
    Total Cash From Operating Activities-10,309,000USD14,208,000USD30,917,000USD24,859,000USD61,978,000USD5,466,000USD-33,528,000USD-60,739,000USD
    Capital Expenditures-14,151,000USD-10,032,000USD-24,364,000USD-33,898,000USD-31,220,000USD-17,678,000USD-6,234,000USD-1,857,000USD
    Free Cash Flow-24,460,000USD4,176,000USD6,553,000USD-9,039,000USD30,758,000USD-12,212,000USD-39,762,000USD-62,596,000USD
    Total Cashflows From Investing Activities-14,151,000USD-10,032,000USD-24,364,000USD-33,898,000USD-31,220,000USD-23,498,000USD-6,234,000USD-1,856,000USD
    Net Borrowings-1,171,000USD-67,644,000USD-5,173,000USD-2,813,000USD2,236,000USD-15,911,000USD38,149,000USD1,072,000USD
    Total Cash From Financing Activities-17,360,000USD27,637,000USD-5,505,000USD-2,199,000USD-1,036,000USD42,468,000USD78,727,000USD81,642,000USD
    Dividends Paid-11,370,000USD-1,798,000USD—-648,000USD-1,461,000USD—-57,897,000USD—
    Sale Purchase Of Stock0USD-25,479,000USD-332,000USD-648,000USD-737,000USD61,896,000USD-6,762,000USD119,000USD
    Issuance Of Capital Stock0USD120,688,000USD0USD0USD0USD64,729,000USD50,340,000USD92,000,000USD
    Change In Cash-41,820,000USD31,813,000USD1,048,000USD-11,238,000USD29,722,000USD24,436,000USD38,965,000USD19,047,000USD
    Begin Period Cash Flow136,151,000USD104,338,000USD103,290,000USD114,528,000USD84,806,000USD60,370,000USD21,405,000USD2,358,000USD
    End Period Cash Flow94,331,000USD136,151,000USD104,338,000USD103,290,000USD114,528,000USD84,806,000USD60,370,000USD21,405,000USD
    Other Cashflows From Financing Activities-16,346,000USD122,558,000USD-332,000USD814,000USD-1,220,000USD-6,350,000USD111,897,000USD-11,430,000USD
    Unclassified Operating Cash Flow9,500,000USD-10,719,000USD2,012,000USD1,980,000USD-31,976,000USD———
    Unclassified Financing Cash Flow11,527,000USD——1,096,000USD—2,833,000USD-6,660,000USD91,881,000USD
    Investments—-10,032,000USD-31,696,000USD-33,898,000USD-31,220,000USD-24,833,000USD-6,234,000USD-1,856,000USD
    Unclassified Investing Cash Flow—10,032,000USD31,696,000USD33,898,000USD31,220,000USD16,881,000USD4,102,000USD1,856,000USD
    Change To Liabilities———-8,518,000USD6,436,000USD-635,000USD4,700,000USD-60,000USD
    Cash And Cash Equivalents Changes———-11,238,000USD29,722,000USD24,436,000USD——
    Other Cashflows From Investing Activities—————2,132,000USD2,132,000USD1,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductGrant950,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct42,805,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductGrant978,000USD0001661181-26-000008
    Q1 2026Quarterly · 2026-03-31ProductProduct36,250,000USD0001661181-26-000008
    Q4 2025Quarterly · 2025-12-31ProductGrant536,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct225,071,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductGrant1,139,000USD0001193125-26-076730
    FY 2025Yearly · 2025-12-31ProductProduct563,030,000USD0001193125-26-076730
    Q3 2025Quarterly · 2025-09-30ProductGrant377,000USD0001193125-25-269697
    Q3 2025Quarterly · 2025-09-30ProductProduct150,487,000USD0001193125-25-269697
    Q2 2025Quarterly · 2025-06-30ProductGrant226,000USD0000950170-25-105048
    Q2 2025Quarterly · 2025-06-30ProductProduct100,779,000USD0000950170-25-105048
    Q1 2025Quarterly · 2025-03-31ProductGrant0USD0001661181-26-000008
    Q1 2025Quarterly · 2025-03-31ProductProduct86,693,000USD0001661181-26-000008
    Q4 2024Quarterly · 2024-12-31ProductAdvanced Wound Care118,585,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSurgical And Sports Medicine8,071,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductGrant0USD0001193125-26-076730
    FY 2024Yearly · 2024-12-31ProductProduct482,043,000USD0001193125-26-076730
    Q3 2024Quarterly · 2024-09-30ProductGrant0USD0001193125-25-269697
    Q3 2024Quarterly · 2024-09-30ProductProduct115,177,000USD0001193125-25-269697
    FY 2023Yearly · 2023-12-31ProductGrant0USD0001193125-26-076730
    FY 2023Yearly · 2023-12-31ProductProduct433,140,000USD0001193125-26-076730
    FY 2022Yearly · 2022-12-31ProductAdvanced Wound Care422,231,000USD0000950170-25-029137
    FY 2022Yearly · 2022-12-31ProductSurgical And Sports Medicine28,662,000USD0000950170-25-029137
    FY 2021Yearly · 2021-12-31ProductAdvanced Wound Care430,237,000USD0000950170-24-023150
    FY 2021Yearly · 2021-12-31ProductSurgical And Sports Medicine37,122,000USD0000950170-24-023150
    FY 2020Yearly · 2020-12-31ProductAdvanced Wound Care294,624,000USD0000950170-23-005585
    FY 2020Yearly · 2020-12-31ProductSurgical And Sports Medicine43,674,000USD0000950170-23-005585
    FY 2019Yearly · 2019-12-31ProductAdvanced Wound Care220,744,000USD0001193125-22-061686
    FY 2019Yearly · 2019-12-31ProductSurgical And Sports Medicine40,237,000USD0001193125-22-061686
    FY 2018Yearly · 2018-12-31ProductAdvanced Wound Care164,332,000USD0001193125-21-082849
    FY 2018Yearly · 2018-12-31ProductSurgical And Sports Medicine29,117,000USD0001193125-21-082849

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.